CD39 deletion in TCR-engineered T cells enhances antitumour immunity
CD39 deletion in TCR-engineered T cells enhances antitumour immunity
About this item
Full title
CD39 deletion in TCR-engineered T cells enhances antitumour immunity
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and British Society of Gastroenterology
Journal title
Gut, 2024-05, Vol.73 (5), p.716-717
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and British Society of Gastroenterology
Subjects
More information
Alternative Titles
Full title
CD39 deletion in TCR-engineered T cells enhances antitumour immunity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2883581857
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2883581857
Other Identifiers
ISSN
0017-5749,1468-3288
E-ISSN
1468-3288
DOI
10.1136/gutjnl-2023-330424
